搜索
Search
这是描述信息

News Center

/
News Center
The birth of Likang V-01 indicates a new leap in R&D and innovation
The
Expert consensus: Livzon Antiviral Granules are recommended for mild and common infections of COVID-19
Expert
Livzon Rapid Test for 2019-nCoV-2 Antigen (Lateral Flow) approved by China NMPA.
Livzon
Code of Labor Employment and Ethical Conduct of Livzon Group
Code
1. To regulate the employment management and ethical conduct of Livzon Pharmaceutical Group Inc. and its units (hereinafter referred to as “Livzon Group” or “we”), the Code is formulated in accordance with the International Labor Organization Conventions and relevant laws, regulations, and policies of the People’s Republic of China.



2. The scope of application of the Code is Livzon Group and all of its employees (including permanent employees, part-time employees and temporary employees), as well as all clients, suppliers, service providers, contractors and other partners that have business relationship with Livzon Group (hereinafter collectively referred to as “relevant personnel”). Each unit shall fully abide by the Code while making its own human resources and related policies.
View details
1. To regulate the employment management and ethical conduct of Livzon Pharmaceutical Group Inc. and its units (hereinafter referred to as “Livzon Group” or “we”), the Code is formulated in accordance with the International Labor Organization Conventions and relevant laws, regulations, and policies of the People’s Republic of China.



2. The scope of application of the Code is Livzon Group and all of its employees (including permanent employees, part-time employees and temporary employees), as well as all clients, suppliers, service providers, contractors and other partners that have business relationship with Livzon Group (hereinafter collectively referred to as “relevant personnel”). Each unit shall fully abide by the Code while making its own human resources and related policies.
Employee Grievance Management System of Livzon Group
Employee
A Recombinant SARS-Cov-2 Fusion Protein Vaccine (V-01) developed and manufactured by Livzon has shown good protective effects against the Omicron variant in a phase III clinical booster trial
A
Livzon Pharmaceutical Group was recognized as the National Enterprise Technology Center with High Scores
Livzon
Livzon participated in the 39th Annual JP Morgan Medical Health Conference
Livzon
Previous page
1
2
3
4
5
6

Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China    Tel: 0756-8135888    

©2021 Livzon  粤ICP备05025993号  Support:300.cn

Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China  

©2021 Livzon   粤ICP备05025993号  

 Support:300.cn